Chinese Traditional and Herbal Drugs
|
2025, 56(21): 8005-8014
Pathogenesis and management strategies of hypercoagulable state in malignant tumors: Integrating traditional Chinese and Western medicine
Full
YAO Shuning1, SUN Wanting2, CHEN Zhenyu1, LIU Lu1, WANG Yuefei1,3
Affiliations
1 National Key Laboratory of Chinese Medicine Modernization, Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;
2 College of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;
3 Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, China
doi: 10.7501/j.issn.0253-2670.2025.21.029
Outline
The incidence of cancer in China continues to rise with pronounced geographical heterogeneity, posing a formidable public health challenge that endangers human life and health while affecting socioeconomic development. The hypercoagulable state in patients with tumors is not only a pivotal pathological hallmark but also a key risk factor for thromboembolic events. Furthermore, it drives tumor angiogenesis, immune evasion, and metastasis through remodeling the tumor microenvironment. In traditional Chinese medicine (TCM), this hypercoagulable state is regarded as “blood stasis”, whose pathogenesis involves the superposition between qi-blood dysfunction and the accumulation of phlegm-dampness stasis. Guided by the principles of “replenishing qi and nourishing blood” and “activating blood and resolving stasis,” TCM exhibits unique advantages in regulating the coagulation system via multi-targeted interventions. This paper systematically expounds on the mechanisms and clinical translational significance of TCM-based interventions in tumor-associated hypercoagulability, with a focus on exploring how TCM compound formulas, single herbs, and their active constituents exert anticoagulant effects. Specifically, it examines their roles in modulating the inflammation-coagulation crosstalk network, ameliorating vascular endothelial function, and suppressing aberrant platelet activation. The study aims to provide novel integrated TCM-Western medicine strategies for optimizing approaches to cancer prevention and treatment.
malignant tumors
/
hypercoagulable state
/
imbalance between coagulation and fibrinolysis
/
traditional Chinese medicine formulas
/
traditional Chinese medicine therapy
姚舒宁, 孙婉婷, 陈珍雨, 刘璐, 王跃飞.
恶性肿瘤所致高凝状态的病理机制与中西医防治研究.
中草药,
2025
, 56
(21)
: 8005
-8014
.
DOI: 10.7501/j.issn.0253-2670.2025.21.029
YAO Shuning, SUN Wanting, CHEN Zhenyu, LIU Lu, WANG Yuefei.
Pathogenesis and management strategies of hypercoagulable state in malignant tumors: Integrating traditional Chinese and Western medicine[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(21)
: 8005
-8014
.
DOI: 10.7501/j.issn.0253-2670.2025.21.029
Year 2025 volume 56 Issue 21
52
12
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.21.029
- Receive Date:2025-07-01
- Online Date:2026-11-13